These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7047483)

  • 1. Analytical methods for microbiology in the next decade.
    Feldman J
    J Assoc Off Anal Chem; 1982 May; 65(3):535-41. PubMed ID: 7047483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxins and medical devices.
    Ross VC; Twohy CW
    Prog Clin Biol Res; 1985; 189():267-81. PubMed ID: 4048209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing medical disposables using the Limulus Amoebocyte Lysate (LAL) test.
    Pfeiffer M
    Med Device Technol; 1990; 1(3):37-41, 51. PubMed ID: 10149427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amendments to sterility test requirements for biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(86):26162-75. PubMed ID: 22606719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin testing of medical devices with LAL: FDA requirements.
    Ross VC; Bruch CW
    Prog Clin Biol Res; 1982; 93():39-48. PubMed ID: 6750646
    [No Abstract]   [Full Text] [Related]  

  • 6. Why and how to implement a rapid sterility test.
    Gressett G; Vanhaecke E; Moldenhauer J
    PDA J Pharm Sci Technol; 2008; 62(6):429-44. PubMed ID: 19634346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; immunology and microbiology devices; classification of the endotoxin assay. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(211):62007-8. PubMed ID: 14594019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice.
    Fed Regist; 1998 Jan; 63(18):4272-3. PubMed ID: 10177326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and setting endotoxin limits.
    Weary ME
    J Parenter Sci Technol; 1990; 44(1):16-8. PubMed ID: 2313486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA guideline for validation of the LAL test as an end-product endotoxin test for human and biological drugs.
    Munson TE
    Prog Clin Biol Res; 1982; 93():25-32. PubMed ID: 7122593
    [No Abstract]   [Full Text] [Related]  

  • 11. Collaborative study of a method for the determination of commercial sterility of low-acid canned foods.
    Denny CB
    J Assoc Off Anal Chem; 1972 May; 55(3):613-6. PubMed ID: 4558008
    [No Abstract]   [Full Text] [Related]  

  • 12. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.
    Moldenhauer J
    PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of nonsterility on the activity of Limulus amebocyte lysate.
    Pearson FC; Dubczak J; Nakashima C; Carpenter DF
    J Parenter Sci Technol; 1982; 36(5):196-8. PubMed ID: 6765552
    [No Abstract]   [Full Text] [Related]  

  • 14. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards an improved sterility test.
    Moldenhauer J; Sutton SV
    PDA J Pharm Sci Technol; 2004; 58(6):284-6. PubMed ID: 15663059
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems of sampling and analytical methods.
    Horwitz W
    J Assoc Off Anal Chem; 1976 Nov; 59(6):1197-203. PubMed ID: 993172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bacterial endotoxin test in the PET facility.
    Williams CC; Borchert RD; Clanton JA
    J Nucl Med; 1993 Mar; 34(3):469-73. PubMed ID: 8441042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant formula record and record retention requirements--FDA. Final rule.
    Fed Regist; 1991 Dec; 56(247):66566-73. PubMed ID: 10116071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology devices; reclassification of hepatitis A virus serological assays. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Feb; 71(27):6677-9. PubMed ID: 16502543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.